Pfizer earnings were $7.9B for the trailing 12 months ending Mar 30, 2025, with N/A growth year over year. The latest PFE earnings report on Mar 30, 2025 announced Q1 2025 earnings of $3.0B, up 623.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PFE reported annual earnings of $8.0B, with 279% growth. The next PFE earnings date is Aug 5, 2025.
PFE past earnings growth
How has PFE's earnings growth performed historically?
On PFE's earnings call on Invalid Date, Pfizer (NYSE: PFE) reported Q1 2025 earnings per share (EPS) of $0.52, up 5.45% year over year. Total PFE earnings for the quarter were $2.97 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.55.
The next PFE earnings date is Invalid Date. Add PFE to your watchlist to be reminded of Pfizer's next earnings date.
Is Pfizer profitable or losing money?
As of the last Pfizer earnings report, Pfizer is currently profitable. Pfizer's net profit (also called net income) for the twelve months ending Mar 30, 2025 was $7.88 billion, a 2,651.13% decrease year over year.
What was PFE's earnings growth in the past year?
As of Pfizer's earnings date in Invalid Date, Pfizer's earnings has grown year over year. PFE earnings in the past year totalled $7.88 billion.
What are Pfizer's earnings expectations?
The current EPS estimate for Pfizer's earnings report in Invalid Date is $0.56.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.